Elena L. Colomer-Gras

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development.

Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development.

Journal: Frontiers in pharmacology

Published: September 10, 2025

[Translated article] OrPhar-SEFH 2024-2027 Strategic Plan.

[Translated article] OrPhar-SEFH 2024-2027 Strategic Plan.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: December 23, 2024

Personalized Secukinumab Treatment in Patients with Plaque Psoriasis Using Model-Informed Precision Dosing.

Personalized Secukinumab Treatment in Patients with Plaque Psoriasis Using Model-Informed Precision Dosing.

Journal: Pharmaceutics

Published: October 31, 2024

Model-Informed Precision Dosing for Personalized Ustekinumab Treatment in Plaque Psoriasis.

Model-Informed Precision Dosing for Personalized Ustekinumab Treatment in Plaque Psoriasis.

Journal: Pharmaceutics

Published: September 03, 2024

Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain.

Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain.

Journal: Medicina clinica

Published: December 23, 2023

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes.

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes.

Journal: Biology

Published: July 17, 2023

Activation and disease control of patients on chronic hemodialysis: An observational study.

Activation and disease control of patients on chronic hemodialysis: An observational study.

Journal: Nefrologia

Published: December 23, 2022

Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis.

Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis.

Journal: Pharmaceutics

Published: February 03, 2022

Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics.

Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: November 12, 2021

Quantitative assessment of the exposure-efficacy relationship of glucocerebrosidase using Markovian elements in Gaucher patients treated with enzyme replacement therapy.

Quantitative assessment of the exposure-efficacy relationship of glucocerebrosidase using Markovian elements in Gaucher patients treated with enzyme replacement therapy.

Journal: British journal of clinical pharmacology

Published: June 21, 2021

Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use.

Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use.

Journal: European journal of hospital pharmacy : science and practice

Published: February 16, 2018

Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I.

Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I.

Journal: Basic & clinical pharmacology & toxicology

Published: October 08, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026